Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
With
Trium Analysis Online GmbH
mca Berlin
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
metastatic pancreatic carcinoma
no previous therapy in the metastatic stage
planned firstline therapy with nab-paclitaxel and gemcitabine
You may not be if
previous therapy in the metastatic stage
patient unable to understand the study and to give informed consent
patient unable to answer quality of life questionnaires
Clareo Health | Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program
